Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis Publisher Pubmed



Momeni F1 ; Ghaemmaghami AB2 ; Nejati M3 ; Pourhanifeh MH4 ; Sichani LS5 ; Tamtaji OR6 ; Momeni M7 ; Khosravi A8 ; Etemadifar M9, 10 ; Mirzaei H6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Research Committee of Multiple Sclerosis, Alzahra Research Institute, Alzahra hospital, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Psychology, Behaviour, Genetics, and Neurobiology Program, University of Toronto, Toronto, Canada
  3. 3. Anatomical Sciences Research Center, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
  4. 4. Halal Research Center of IRI, FDA, Tehran, Iran
  5. 5. Department of Genetic, Faculty of Basic Science, University of Shahrekord, Shahrekord, Iran
  6. 6. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
  7. 7. Department of Radiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  8. 8. Clinical Immunology Research Center, Department of Neurology, School of Medicine, Zahedan University of Medical Science, Zahedan, Iran
  9. 9. Department of Neurology, Isfahan University of Medical Sciences, Iran
  10. 10. Isfahan Research Committee of Multiple Sclerosis, Alzahra Research Institute, Alzahra Hospital, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran

Source: Current Medicinal Chemistry Published:2020


Abstract

Multiple Sclerosis (MS), an autoimmune disorder associated with spinal cord and brain, chiefly affects the white matter. Regarding the complexity as well as heterogenic etiology of this disease, the treatment of MS has been a challenging issue up to now. Researchers are working to develop new therapeutic strategies and drugs as complementary therapies. MS diagnosis significantly depends on the findings of Magnetic Resonance Imaging (MRI) examination. In this imaging technique, gadolinium is used as a contrast agent to reveal active plaques intending to destroy the bloodbrain barrier. It also detects plaques that are not correlated with the neurological symptoms. It has been attempted to determine biomarkers related to different dimensions of MS in various organizational hierarchy levels of the human anatomy (i.e., cells, proteins, RNA, and DNA). These biomarkers are appropriate diagnostic tools for MS diagnosis. In this review, we summarized the application of MRI and biochemical biomarkers to monitor MS patients. Moreover, we highlighted the joint application of MRI and biomarkers for the diagnosis of MS subjects. © 2020 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Micrornas: Key Modulators of Disease-Modifying Therapies in Multiple Sclerosis : Pancreatic Cancer Is One of the Lethal Malignant Tumours in the World.In This Study, We Investigated the Car T-Cell Therapy of Pancreatic Cancer, International Reviews of Immunology (2020)
2. The Role of Micrornas Involved in the Disorder of Blood–Brain Barrier in the Pathogenesis of Multiple Sclerosis, Frontiers in Immunology (2023)
3. Comparison of Expression Levels of Mir-29B-3P and Mir-326 in T Helper-1 and T Helper-17 Cells Isolated From Responsive and Non-Responsive Relapsing-Remitting Multiple Sclerosis Patients Treated With Interferon-Beta, Iranian Journal of Allergy, Asthma and Immunology (2020)
4. Comparison of Susceptibility-Weighted Imaging With Contrast Enhancement in Detection of Multiple Sclerosis Active Plaques Using 1.5 Tesla Magnetic Resonance Imaging System, Journal of Isfahan Medical School (2017)
5. Mir-145 and Mir20a-5P Potentially Mediate Pleiotropic Effects of Interferon-Beta Through Mitogen-Activated Protein Kinase Signaling Pathway in Multiple Sclerosis Patients, Journal of Molecular Neuroscience (2017)
6. Conversion From Radiologically Isolated Syndrome to Multiple Sclerosis, International Journal of Preventive Medicine (2014)
7. The Diagnostic Performance of Ai-Based Algorithms to Discriminate Between Nmosd and Ms Using Mri Features: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
8. Mri Features and Disability in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2024)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (33)
Vahid Shaygannejad (27)
Other Related Docs
9. Investigating the Feasibility of Differentiating Ms Active Lesions From Inactive Ones Using Texture Analysis and Machine Learning Methods in Dwi Images, Multiple Sclerosis and Related Disorders (2024)
10. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
11. Evaluating the Effects of Epigallocatechin-3-Gallate on Hif-1Α Protein and Rorc Gene Expression in Peripheral Blood Mononuclear Cells in Patients With Multiple Sclerosis, Basic and Clinical Neuroscience (2021)
12. The Effect of Interferon-Beta Therapy on T-Helper 17/Mir-326 and T-Helper 1/Mir-29B-3P Axis in Relapsing-Remitting Multiple Sclerosis Patients, NeuroImmunoModulation (2022)
13. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
14. Analysis of the Expression of Mir-34A, Mir-199A, Mir-30C and Mir-19A in Peripheral Blood Cd4+T Lymphocytes of Relapsing-Remitting Multiple Sclerosis Patients, Gene (2018)
15. Assessment of Axonal Injury in Multiple Sclerosis: Combined Analysis of Serum Light-Chain Neurofilaments and Diffusion Tensor Imaging, BMJ Neurology Open (2024)
16. Gastric Cancer Diagnosis: From Imaging Techniques to Biochemical Biomarkers, Current Molecular Medicine (2021)
17. Cervical Cancer Diagnosis: Insights Into Biochemical Biomarkers and Imaging Techniques, Combinatorial Chemistry and High Throughput Screening (2021)
18. Evaluation of the Relationship Between Axon Injury and Clinical Symptoms in Patients With Multiple Sclerosis Using Diffusion Tensor Mri Imaging; [بررسی ارتباط آسیب آکسون با علایم بالینی در بیماران مبتلا به مالتیپل اسکلروزیس Mri با استفاده از تصویربرداري انتشار تانسوري], Tehran University Medical Journal (2022)
19. Mir-504 Expression Level Is Increased in Multiple Sclerosis Patients Responder to Interferon-Beta, Journal of Neuroimmunology (2020)
20. Multiple Sclerosis: Clinical Features, Pathophysiology, Neuroimaging and Future Therapies, Future Neurology (2009)
21. Optimal B-Value in Diffusion Weighted Imaging for Detection Active Multiple Sclerosis Plaque, Using Contrast Enhancement Imaging, Journal of Isfahan Medical School (2021)
22. Cytokine Gene Expression in Newly Diagnosed Multiple Sclerosis Patients, Iranian Journal of Allergy, Asthma and Immunology (2015)
23. Association Between Diffusion Tensor Imaging Measurements and Cognitive Performances in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2025)
24. Promising Effect of Rapamycin on Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2018)
25. Concurrent Glioma and Multiple Sclerosis: A Systematic Review of Case Reports, Multiple Sclerosis and Related Disorders (2024)
26. Serum Uric Acid Level in Patients With Relapsing-Remitting Multiple Sclerosis, Journal of Clinical Neuroscience (2013)
27. T1 and T2 Weighted Lesions and Cognition in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2024)
28. Seizure in Iranian Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2013)
29. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
30. Effect of Deep Gray Matter Atrophy on Information Processing Speed in Early Relapsing-Remitting Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2023)
31. Elevated Csf Concentration of Ccl3 and Ccl4 in Relapsing Remitting Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
32. Connection of Mir-185 and Mir-320A Expression Levels With Response to Interferon-Beta in Multiple Sclerosis Patients, Multiple Sclerosis and Related Disorders (2020)
33. Apamin Administration Impact on Mir-219 and Mir-155-3P Expression in Cuprizone Induced Multiple Sclerosis Model, Molecular Biology Reports (2020)
34. Evaluation of the Expressed Mir‑129 and Mir‑549A in Patients With Multiple Sclerosis, Advanced Biomedical Research (2021)
35. Cognitive Function and Brain Magnetic Resonance Imaging Profiles in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis, Journal of Research in Medical Sciences (2024)
36. Elevated Serum Level of Il-4 in Neuromyelitis Optica and Multiple Sclerosis Patients, Journal of Immunoassay and Immunochemistry (2019)
37. Pure Spinal Multiple Sclerosis: A Case Series of a Possible New Entity, Journal of Neuroimmunology (2025)
38. Myasthenia Gravis During the Course of Neuromyelitis Optica, Case Reports in Neurology (2011)
39. First-Year Treatment Response Predicts the Following 5-Year Disease Course in Patients With Relapsing-Remitting Multiple Sclerosis, Neurotherapeutics (2025)
40. Serum Homocysteine Level in Patients With Multiple Sclerosis, Journal of Research in Medical Sciences (2005)
41. Upregulation of Mtor, Rps6kb1, and Eif4ebp1 in the Whole Blood Samples of Iranian Patients With Multiple Sclerosis Compared to Healthy Controls, Metabolic Brain Disease (2020)
42. Serum Lipids and Cognitive Outcomes in Multiple Sclerosis; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
43. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing–Remitting Multiple Sclerosis Patients, Inflammation (2022)
44. Association of Urodynamic Findings in New Onset Multiple Sclerosis With Subsequent Occurrence of Urinary Symptoms and Acute Episode of Disease in Females, Journal of Research in Medical Sciences (2012)
45. Automatic Detection of Active and Inactive Multiple Sclerosis Plaques Using the Bayesian Approach in Susceptibility-Weighted Imaging, Acta Radiologica (2023)
46. Deep Learning for Discrimination of Active and Inactive Lesions in Multiple Sclerosis Using Non-Contrast Flair Mri: A Multicenter Study, Multiple Sclerosis and Related Disorders (2024)
47. The Effect of Ifn-Β Treatment on Plasma Levels of Bdnf and Il-6 in Relapsing-Remitting Multiple Sclerosis Patients, NeuroImmunoModulation (2021)
48. Bone Loss and Fracture in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2024)
49. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
50. Mri Signs of Cns Demyelinating Diseases, Multiple Sclerosis and Related Disorders (2021)